{"title":"MLL4:在细胞分化、脂肪形成和癌症中的作用。","authors":"Yu Zhang, Kaili Lv, Xubin Ma, Liang Wang, Yichao Xu","doi":"10.1016/j.bcp.2025.117371","DOIUrl":null,"url":null,"abstract":"<p><p>Epigenetic regulation of gene expression plays an important role in cellular biological processes. MLL4 (KMT2D), as a histone lysine methyltransferase, is responsible for the mono-, di- and tri- methylation of histone 3 lysine 4 (H3K4), and H3K4me1 at the super enhancer/enhancer or promoter regions usually couples with H3K27ac to promote the expression of many genes. The biology function of MLL4 in cell proliferation and adipogenesis has been widely reported. And silencing MLL4 prevent the development of obesity and fatty liver, making it a potential target. Furthermore, MLL4 is frequently mutated and loses the methyltransferase activity in multiple cancers. Dual functions of MLL4 in cancer have been reported due to the broad widely distribution of H3K4 in chromatin. The paradoxical function of MLL4 complicate it as the potential target of cancer therapy. Notably, MLL4 may be a biomarker for drug sensitivity or serves as a synthetic lethal gene for specific anti-cancer agents. In this review, we examine the protein structural features of MLL4, discuss the MLL4 action in cell differentiation, adipogenesis, and cancer, and identify current challenges for future investigations.</p>","PeriodicalId":8806,"journal":{"name":"Biochemical pharmacology","volume":" ","pages":"117371"},"PeriodicalIF":5.6000,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The MLL4: Roles in cell differentiation, adipogenesis and cancer.\",\"authors\":\"Yu Zhang, Kaili Lv, Xubin Ma, Liang Wang, Yichao Xu\",\"doi\":\"10.1016/j.bcp.2025.117371\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Epigenetic regulation of gene expression plays an important role in cellular biological processes. MLL4 (KMT2D), as a histone lysine methyltransferase, is responsible for the mono-, di- and tri- methylation of histone 3 lysine 4 (H3K4), and H3K4me1 at the super enhancer/enhancer or promoter regions usually couples with H3K27ac to promote the expression of many genes. The biology function of MLL4 in cell proliferation and adipogenesis has been widely reported. And silencing MLL4 prevent the development of obesity and fatty liver, making it a potential target. Furthermore, MLL4 is frequently mutated and loses the methyltransferase activity in multiple cancers. Dual functions of MLL4 in cancer have been reported due to the broad widely distribution of H3K4 in chromatin. The paradoxical function of MLL4 complicate it as the potential target of cancer therapy. Notably, MLL4 may be a biomarker for drug sensitivity or serves as a synthetic lethal gene for specific anti-cancer agents. In this review, we examine the protein structural features of MLL4, discuss the MLL4 action in cell differentiation, adipogenesis, and cancer, and identify current challenges for future investigations.</p>\",\"PeriodicalId\":8806,\"journal\":{\"name\":\"Biochemical pharmacology\",\"volume\":\" \",\"pages\":\"117371\"},\"PeriodicalIF\":5.6000,\"publicationDate\":\"2025-09-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biochemical pharmacology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.bcp.2025.117371\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biochemical pharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.bcp.2025.117371","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
The MLL4: Roles in cell differentiation, adipogenesis and cancer.
Epigenetic regulation of gene expression plays an important role in cellular biological processes. MLL4 (KMT2D), as a histone lysine methyltransferase, is responsible for the mono-, di- and tri- methylation of histone 3 lysine 4 (H3K4), and H3K4me1 at the super enhancer/enhancer or promoter regions usually couples with H3K27ac to promote the expression of many genes. The biology function of MLL4 in cell proliferation and adipogenesis has been widely reported. And silencing MLL4 prevent the development of obesity and fatty liver, making it a potential target. Furthermore, MLL4 is frequently mutated and loses the methyltransferase activity in multiple cancers. Dual functions of MLL4 in cancer have been reported due to the broad widely distribution of H3K4 in chromatin. The paradoxical function of MLL4 complicate it as the potential target of cancer therapy. Notably, MLL4 may be a biomarker for drug sensitivity or serves as a synthetic lethal gene for specific anti-cancer agents. In this review, we examine the protein structural features of MLL4, discuss the MLL4 action in cell differentiation, adipogenesis, and cancer, and identify current challenges for future investigations.
期刊介绍:
Biochemical Pharmacology publishes original research findings, Commentaries and review articles related to the elucidation of cellular and tissue function(s) at the biochemical and molecular levels, the modification of cellular phenotype(s) by genetic, transcriptional/translational or drug/compound-induced modifications, as well as the pharmacodynamics and pharmacokinetics of xenobiotics and drugs, the latter including both small molecules and biologics.
The journal''s target audience includes scientists engaged in the identification and study of the mechanisms of action of xenobiotics, biologics and drugs and in the drug discovery and development process.
All areas of cellular biology and cellular, tissue/organ and whole animal pharmacology fall within the scope of the journal. Drug classes covered include anti-infectives, anti-inflammatory agents, chemotherapeutics, cardiovascular, endocrinological, immunological, metabolic, neurological and psychiatric drugs, as well as research on drug metabolism and kinetics. While medicinal chemistry is a topic of complimentary interest, manuscripts in this area must contain sufficient biological data to characterize pharmacologically the compounds reported. Submissions describing work focused predominately on chemical synthesis and molecular modeling will not be considered for review.
While particular emphasis is placed on reporting the results of molecular and biochemical studies, research involving the use of tissue and animal models of human pathophysiology and toxicology is of interest to the extent that it helps define drug mechanisms of action, safety and efficacy.